Who are the top shareholders of the Murae Organisor?

The top shareholders of Murae Organisor include individual investors with 60.02% of the shares, while Ifl Enterprises Limited holds 7.34%. Auxilia Pharmaceuticals Private Limited is the promoter with a reported stake of 0.0%, and there are no institutional holdings.

The top shareholders of Murae Organisor include individual investors, who hold a significant 60.02% of the shares. The highest public shareholder is Ifl Enterprises Limited, with a holding of 7.34%. Additionally, Auxilia Pharmaceuticals Private Limited is noted as the promoter with the highest holding, although their stake is listed as 0.0%. There are no institutional holdings from mutual funds or foreign institutional investors.

how big is Murae Organisor?

As of Jun 06, Murae Organisor Ltd has a market capitalization of 208.20 Cr, classifying it as a Micro Cap company, with recent net sales of 854.82 Cr and a net profit of 7.52 Cr. The standalone balance sheet shows shareholder's funds of 55.85 Cr and total assets of 119.86 Cr.

Market Cap: As of Jun 06, Murae Organisor Ltd has a market capitalization of 208.20 Cr, which classifies it as a Micro Cap company.<BR><BR>Recent Quarterly Performance: For the latest four quarters, Murae Organisor reported Net Sales of 854.82 Cr and a Net Profit of 7.52 Cr. This data is based on Standalone financials.<BR><BR>Balance Sheet Snapshot: The Standalone balance sheet for the reporting period ending in Mar'24 shows Shareholder's Funds of 55.85 Cr and Total Assets of 119.86 Cr.

What is the bonus history of the Murae Organisor?

Murae Organisor issued a 1:1 bonus on August 9, 2021, with a record date of August 10, 2021, meaning shareholders received an additional share for each share owned as of that date.

Murae Organisor has a bonus history that includes a 1:1 bonus issue announced on August 9, 2021. The record date for this bonus was August 10, 2021. This means that shareholders received an additional share for every share they owned as of the record date. If you have any more questions about the company or its financials, feel free to ask!

Has Murae Organisor declared dividend?

No Dividend History Available

Who are the peers of the Murae Organisor?

Murae Organisor's peers include Sun Pharma, Divi's Lab, Cipla, Torrent Pharma, Dr Reddy's Labs, Krebs Biochem, Auro Labs, Bal Pharma, Amwill, and Aarey Drugs. Murae Organisor has below average management and capital structure risks, with a 1-year return of 27.92%, compared to Divi's Lab's highest return of 51.96% and Bal Pharma's lowest at -13.63%.

Peers: The peers of Murae Organisor are Sun Pharma.Inds., Divi's Lab., Cipla, Torrent Pharma, Dr Reddy's Labs, Krebs Biochem, Auro Labs., Bal Pharma, Amwill, and Aarey Drugs.<BR><BR>Quality Snapshot: Excellent management risk is observed at Sun Pharma.Inds., Cipla, Dr Reddy's Labs, Auro Labs., and Amwill, while Good management risk is found at Divi's Lab., Torrent Pharma, and Bal Pharma. Below Average management risk is noted for Murae Organisor, and Average management risk is present at Aarey Drugs. Growth is Excellent for Sun Pharma.Inds., Cipla, Dr Reddy's Labs, and Murae Organisor, while Below Average growth is seen at Divi's Lab. and Torrent Pharma. Good growth is noted at Bal Pharma and Amwill, and the rest have varying growth ratings. Excellent capital structure is found at Sun Pharma.Inds., Cipla, Dr Reddy's Labs, and Auro Labs., while Good capital structure is noted at Torrent Pharma and Amwill. Below Average capital structure is observed at Murae Organisor and Bal Pharma, and Krebs Biochem does not qualify.<BR><BR>Return Snapshot: Divi's Lab. has the highest 1-year return at 51.96%, while Bal Pharma has the lowest at -13.63%. Murae Organisor's 1-year return is 27.92%, which is significantly higher than Bal Pharma's but lower than Divi's Lab.'s. Additionally, Krebs Biochem and Amwill have negative six-month returns.

What is the technical trend for Murae Organisor?

As of June 2, 2025, Murae Organisor's technical trend is mildly bullish, supported by positive weekly and monthly MACD and Bollinger Bands, despite some short-term bearish signals from daily moving averages and mixed KST indicators.

As of 2 June 2025, the technical trend for Murae Organisor has changed from sideways to mildly bullish. The weekly MACD is bullish, supporting the positive sentiment, while the monthly MACD is mildly bullish. Bollinger Bands are bullish on both weekly and monthly time frames, indicating upward price momentum. The Dow Theory also reflects a mildly bullish stance on both weekly and monthly charts. However, the daily moving averages are mildly bearish, which suggests some short-term weakness. The KST shows a bearish signal on the weekly but is bullish on the monthly, indicating mixed signals across time frames. Overall, the current technical stance is mildly bullish, driven primarily by the positive MACD and Bollinger Bands on the weekly and monthly charts.

Who are in the management team of Murae Organisor?

As of March 2021, the management team of Murae Organisor includes Bhumishth Narendrabhai Patel as Chairman & Managing Director, Payal Bhumishth Patel as Whole Time Director & CFO, and several independent and additional directors, along with a Company Secretary.

As of March 2021, the management team of Murae Organisor includes the following individuals:<BR><BR>1. Bhumishth Narendrabhai Patel - Chairman & Managing Director<BR>2. Bhumishth Narendrabhai Patel - Non Executive Director<BR>3. Payal Bhumishth Patel - Whole Time Director & CFO<BR>4. Bhavik Shantilal Patel - Independent Director<BR>5. Dahyabhai Mafatlal Patel - Additional Non-Executive Director<BR>6. Parimal S Patwa - Additional Independent Director<BR>7. Harsh M Kothari - Additional Independent Director<BR>8. Madhuri Mistry - Company Secretary & Compliance Officer<BR>9. Sumitkumar Patel - Independent Director<BR>10. Premaram Patel - Additional Director<BR>11. Sanjaykumar Nai - Additional Director<BR>12. Vijaykumar Patel - Additional Director<BR><BR>This team comprises a mix of executive, independent, and additional directors, along with a compliance officer.

What does Murae Organisor do?

Murae Organisor Ltd is a Micro Cap company in the Pharmaceuticals & Biotechnology industry, reporting net sales of 5,155 Cr and a net profit of 28 Cr for the quarter ending March 2025. Originally founded as Earum Pharmaceuticals in 2012, it became a public company in 2019.

Overview:<BR>Murae Organisor Ltd operates in the Pharmaceuticals & Biotechnology industry and is categorized as a Micro Cap company.<BR><BR>History:<BR>Murae Organisor Ltd was originally incorporated as "Earum Pharmaceuticals Private Limited" in 2012. The company transitioned to a Public Limited status and changed its name to "Earum Pharmaceuticals Limited" in January 2019. The most recent quarterly results reported net sales and net profit for the period ending March 2025.<BR><BR>Financial Snapshot:<BR>Net Sales: 5,155 Cr (Quarterly Results - Mar 2025) <BR>Net Profit: 28 Cr (Quarterly Results - Mar 2025) <BR>Market Cap: INR 180 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: 24.00 <BR>Industry P/E: 20 <BR>Dividend Yield: 0.00% <BR>Debt Equity: -0.21 <BR>Return on Equity: 13.47% <BR>Price to Book: 3.40 <BR><BR>Contact Details:<BR>No Company Details Available <BR>Registrar Address: Not available.

Is Murae Organisor overvalued or undervalued?

As of August 14, 2025, Murae Organisor is considered undervalued with a PE Ratio of 16.86 and an EV to EBIT of 11.47, making it an attractive investment opportunity despite a year-to-date stock performance of -70.05% compared to the Sensex's 3.15%.

As of 14 August 2025, Murae Organisor has moved from a grade of risky to very attractive, indicating a significant improvement in its valuation outlook. The company is currently considered undervalued based on its financial metrics. Key ratios include a PE Ratio of 16.86, an EV to EBIT of 11.47, and a PEG Ratio of 0.01, which suggests that the stock is trading at a low valuation relative to its growth potential.<BR><BR>In comparison to its peers, Murae Organisor stands out with a much lower PE Ratio than Sun Pharma (34.24) and Divi's Lab (70.57), both of which are classified as expensive. Additionally, Murae's EV to EBITDA ratio of 11.47 is more favorable than many competitors, reinforcing its undervaluation status. Despite recent poor stock performance against the Sensex, with a year-to-date return of -70.05% compared to the Sensex's 3.15%, the valuation metrics suggest that Murae Organisor presents a compelling investment opportunity at its current price.

When is the next results date for Murae Organisor?

Murae Organisor will declare its results on 22 August 2025.

Murae Organisor will declare its results on 22 August 2025.

Are Murae Organisor latest results good or bad?

Murae Organisor's latest results show strong net sales growth of over 225,000% and a 296% increase in Profit After Tax, indicating improved profitability. However, a 62.5% decline in Profit Before Tax raises concerns about sustainability, leading to a current stock rating of 'Hold'.

Murae Organisor's latest results present a mixed picture. On one hand, the company has reported a remarkable increase in net sales, reaching Rs 519.52 crore, which reflects an extraordinary year-on-year growth of over 225,000%. This indicates strong market performance and suggests that the company is successfully expanding its sales.<BR><BR>Additionally, the Profit After Tax (PAT) of Rs 7.44 crore represents a substantial increase of nearly 296% compared to the average PAT of the previous four quarters. This is the highest PAT recorded in the last five quarters, indicating a positive trend in profitability and improved earnings for shareholders, as reflected in the Earnings per Share (EPS) of Rs 0.07.<BR><BR>However, there are notable concerns regarding the Profit Before Tax (PBT), which has decreased by 62.5% from the previous average, falling to Rs 0.94 crore. A significant portion of this PBT is attributed to non-operating income, which raises questions about the sustainability of the company’s core business operations. <BR><BR>Overall, while Murae Organisor shows strong sales growth and improved profitability metrics, the decline in PBT and reliance on non-operating income suggest potential challenges ahead. The stock is currently rated as a 'Hold', indicating that while there are positive aspects, caution may be warranted.

How has been the historical performance of Murae Organisor?

Murae Organisor has shown significant growth in net sales, increasing from 55.11 Cr in March 2020 to 854.82 Cr in March 2025, alongside improvements in profitability metrics, despite challenges in cash flow management. The company's equity capital rose substantially, reflecting a strong capital base during this recovery phase.

Answer:<BR>The historical performance of Murae Organisor shows significant fluctuations in its financial metrics over the years, particularly from March 2019 to March 2025.<BR><BR>Breakdown:<BR>Murae Organisor's net sales have dramatically increased from 55.11 Cr in March 2020 to 854.82 Cr in March 2025, indicating a substantial growth trajectory. However, total operating income followed a similar pattern, rising from 50.70 Cr in March 2019 to 854.82 Cr in March 2025. The company has maintained a consistent zero in raw material costs and other operating income throughout this period. The total expenditure, excluding depreciation, has also seen a rise, from 47.40 Cr in March 2019 to 844.79 Cr in March 2025. Operating profit (PBDIT) has fluctuated, with a notable recovery to 10.03 Cr in March 2025 after experiencing losses in previous years. Profit before tax has similarly improved to 10.03 Cr in March 2025, up from just 0.07 Cr in March 2024. Profit after tax has also shown a positive trend, reaching 7.52 Cr in March 2025 compared to only 0.05 Cr in March 2024. The company's equity capital has increased significantly from 0.31 Cr in March 2019 to 185.90 Cr in March 2025, reflecting a strong capital base. On the balance sheet, total liabilities rose from 23.25 Cr in March 2019 to 119.86 Cr in March 2024, while total assets mirrored this increase, reaching 119.86 Cr in March 2024. Cash flow from operating activities has been negative in recent years, with a notable outflow of 15.00 Cr in March 2024, although financing activities provided a net inflow of 28.00 Cr in the same period. Overall, Murae Organisor's financial performance indicates a recovery and growth phase, particularly in sales and profitability metrics, despite challenges in cash flow management.

Should I buy, sell or hold Murae Organisor?

Which are the latest news on Murae Organisor?

Why is Murae Organisor falling/rising?

As of 17-Dec, Murae Organisor Ltd's stock price is rising to 0.26, reflecting a 4.0% increase due to strong recent performance and consistent profit growth. However, long-term fundamentals are weak, with significant declines year-to-date and low investor participation, indicating mixed performance.

As of 17-Dec, Murae Organisor Ltd's stock price is rising, currently at 0.26, which reflects a change of 0.01 or 4.0% increase. This rise can be attributed to the company's recent performance, which has shown significant growth in net profit, with a 161.05% increase reported in June. Additionally, the company has declared positive results for the last four consecutive quarters, indicating consistent financial improvement. The latest six months have seen net sales higher at Rs 519.52 crore, and the profit after tax for the latest quarter reached its highest at Rs 7.44 crore, contributing to a favorable earnings per share of Rs 0.07.<BR><BR>Despite the positive financial indicators, the stock has been underperforming over longer periods, with a year-to-date decline of 87.44% and a one-year decline of 87.68%. The stock is also trading below its moving averages, which suggests a lack of momentum. Furthermore, there has been a notable decrease in investor participation, with delivery volume falling by 52.19% against the five-day average. This decline in trading activity may indicate a cautious sentiment among investors despite the recent price increase.<BR><BR>Overall, while Murae Organisor Ltd's stock is experiencing a short-term rise, the long-term fundamentals remain weak, as evidenced by its high debt to EBITDA ratio and average return on equity of 0%. Thus, the stock's performance is mixed, with positive short-term movements overshadowed by significant long-term challenges.